======= OST4 ======= == Gene Information == * **Official Symbol**: OST4 * **Official Name**: oligosaccharyltransferase complex subunit 4, non-catalytic * **Aliases and Previous Symbols**: N/A * **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=100128731|100128731]] * **UniProt**: [[https://www.uniprot.org/uniprot/P0C6T2|P0C6T2]] * **Interactions**: [[https://thebiogrid.org/search.php?search=OST4&organism=9606|BioGRID]] * **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20OST4|Open PubMed]] * **OMIM**: [[https://omim.org/entry/618932|Open OMIM]] == Function Summary == * **Entrez Summary**: N/A * **UniProt Summary**: Acts as component of the N-oligosaccharyl transferase (OST) complex which catalyzes the transfer of a high mannose oligosaccharide from a lipid-linked oligosaccharide donor to an asparagine residue within an Asn-X-Ser/Thr consensus motif in nascent polypeptide chains. Required for efficient N- glycosylation. Specifically involved in maintaining stability of STT3A-containing OST complexes. {ECO:0000269|PubMed:23606741, ECO:0000305}. |Ost4| |oligosaccharyltransferase complex| |protein N-linked glycosylation via asparagine| |peptidyl-asparagine modification| |protein N-linked glycosylation| |protein glycosylation| |macromolecule glycosylation| |glycosylation| |glycoprotein biosynthetic process| |glycoprotein metabolic process| |carbohydrate derivative biosynthetic process| |peptidyl-amino acid modification| |carbohydrate derivative metabolic process| |organonitrogen compound biosynthetic process| |cellular macromolecule biosynthetic process| |macromolecule biosynthetic process| \\ === CRISPR Data === ^Screen^Score^ |[[:results:exp6|Bortezomib 0.005μM R00 exp6]]|-2.71| |[[:results:exp30|Rapamycin 10μM R00 exp30]]|-1.79| |[[:results:exp445|∆-9-Tetrahydrocannabinol 30μM R08 exp445]]|-1.74| |[[:results:exp416|Tubacin 1.6μM R07 exp416]]|-1.71| |[[:results:exp5|Alpha-Amanitin 0.5μM R00 exp5]]|-1.7| |[[:results:exp409|THZ531 0.11μM R07 exp409]]|1.78| |[[:results:exp355|Dinaciclib 0.007μM R07 exp355]]|2.03| |[[:results:exp264|Arsenate 40μM R06 exp264]]|2.48| |[[:results:exp80|RO-3307 4.7μM R02 exp80]]|2.53| |[[:results:exp419|Tunicamycin 0.04 to 0.075μM on day4 R07 exp419]]|2.67| |[[:results:exp418|Tunicamycin 0.04μM R07 exp418]]|3.14| |[[:results:exp420|Tunicamycin 0.04 to 0.125μM on day4 R07 exp420]]|3.46| ^Gene^Correlation^ |[[:human genes:d:ddost|DDOST]]|0.441| |[[:human genes:c:cept1|CEPT1]]|0.428| |[[:human genes:a:alg5|ALG5]]|0.427| |[[:human genes:t:tmem258|TMEM258]]|0.419| |[[:human genes:r:romo1|ROMO1]]|0.411| |[[:human genes:r:rpn2|RPN2]]|0.409| |[[:human genes:s:sec63|SEC63]]|0.408| |[[:human genes:u:ube2j1|UBE2J1]]|0.406| Global Fraction of Cell Lines Where Essential: 16/739 ^Tissue^Fraction Of Cell Lines Where Essential^ |1290807.0|0/1| |909776.0|0/1| |bile duct|1/28| |blood|0/28| |bone|0/26| |breast|0/33| |central nervous system|0/56| |cervix|0/4| |colorectal|0/17| |esophagus|0/13| |fibroblast|0/1| |gastric|0/16| |kidney|2/21| |liver|2/20| |lung|1/75| |lymphocyte|0/16| |ovary|0/26| |pancreas|0/24| |peripheral nervous system|0/16| |plasma cell|0/15| |prostate|0/1| |skin|0/24| |soft tissue|0/9| |thyroid|0/2| |upper aerodigestive|3/22| |urinary tract|1/29| |uterus|0/5| == Essentiality in NALM6 == * **Essentiality Rank**: 6122 * **Expression level (log2 read counts)**: 5.34 {{:chemogenomics:nalm6 dist.png?nolink |}}